EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil)
Series type: Joint Reports
Summary
In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations launched a data collection on this substance for the preparation of a Joint Report as stipulated by Article 5.1 of the Council Decision. The Joint Report was submitted to the Council, the Commission and the European Medicines Agency on 27 July 2017.
Table of contents
- Introduction
- Information collection process
- Information required by Article 5.2 of the Council Decision
- Information from the EMA (Article 5.3 of the Council Decision)
- Conclusion
- References
Main subject:
Pages:
19
Price:
Free
ISBN:
978-92-9497-242-2
ISSN:
1977-7868
Pub. DOI:
10.2810/282222
Catalog Number:
TD-AS-17-009-EN-N